Vicente LLP Psychedelics & Emerging Therapies Update: April 2024

Apr 12, 2024

State News & Insights


Colorado's Draft Natural Medicine Rules: Full Breakdown & Commentary

Vicente LLP and Psychedelic Alpha provide a full breakdown of the first set of draft rules regarding Colorado's regulated psychedelics program with commentary from Vicente. The thirty-nine pages of draft rules cover facilitator licensing and training programs, representing months of work by the Natural Medicine Advisory Board and state regulators. Read more.

Colorado Natural Medicine Advisory Bulletin #8.1: Recommendation Round-Up

Bulletin #8.1 gives context to the 123 recommendations, which will form the basis of the regulated nature medicine program approved by Colorado voters in November 2022. Read more.

Colorado Natural Medicine Advisory Bulletin #9: February/March 2024

Colorado Natural Medicine Advisory Bulletin #9 focuses on updates from the recent meeting of the Natural Medicine Advisory Board and listening sessions held by the Department of Revenue and the Department of Regulatory Agencies Stakeholder Engagement Meeting. Read more.

Colorado Natural Medicine Advisory Bulletin #10: March 2024

Bulletin #10 focuses on updates from the recent Natural Medicine Advisory Board meeting, where draft rules for Facilitator licensing and training were discussed. Read more.

Colorado Natural Medicine Advisory Bulletin #10: Legislative Update

Bulletin #10.1 features our review of SB 24-198, the first legislative update since the passing of SB23-290 in 2023, which implemented the NMHA. Read more.


California Assembly Unanimously Approves Bill to Create Psychedelics Workgroup and Prepare for Legal Therapeutic Access

California lawmakers recently gave a green light to a bill that could change how people deal with mental health problems. This bill, created by a Republican assembly member, would set up a group to look into the rules for using psychedelic drugs like psilocybin and ibogaine for treatment. If the California legislature put in place a regulatory framework as recommended by the workgroup, therapists will eventually be able to give these drugs to patients in a safe and controlled setting, following these new guidelines. Read more.


Maine Senate Passes Bill To Create Psychedelics Commission That Would Explore Regulated Access

Maine lawmakers have advanced an amended bill to establish a commission tasked with studying and making recommendations on regulating access to psychedelic services. The legislation was significantly watered down, as it initially would have legalized psilocybin. The 13-member panel would consist of legislative appointees, health experts, a military veteran, academics and people with experience in psychedelics policy. Read more.


Missouri House Approves Budget Bill With $10 Million To Research Psilocybin As Treatment For Opioid Addiction

Last week, Missouri’s House of Representatives gave final approval to a budget bill that would spend $10 million from state opioid settlement funds to study the use of psilocybin to treat opioid use disorder. Read more.


Utah Psychedelics Pilot Program Bill Becomes Law

The Republican governor of Utah has allowed a bill to become law without his signature that authorizes a pilot program for regulated access to psilocybin and MDMA as an alternative treatment option. Under this pilot program, psilocybin and MDMA may be administered by certain hospitals and universities. Read more.

Federal News & Insights

DEA Agrees to Hold Hearing on Proposed Ban of DOI and DOC

After pushback from researchers, the Drug Enforcement Administration has scheduled an administrative hearing to get additional feedback from experts amid its renewed push to schedule 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) as Schedule I drugs under the Controlled Substances Act (CSA). Read more.

Veterans Mental Health Leadership Coalition Urges Congress to Support and Pass the Breakthrough Therapies Act

In a pivotal series of meetings held in mid-March, the Veterans Mental Health Leadership Coalition (VMHLC), engaged with 65 members of Congress to advocate for the urgent passage of the Breakthrough Therapies Act. This legislation is a cornerstone in the fight against the escalating mental health crisis and its resultant increase in suicide rates and pharmaceutical overdoses within the veteran community. 

Show Your Support

Support Microdosing Research and Advocacy Efforts

The Microdosing Collective is leading a coordinated strategy around changes to state and federal policy to support the legalization of microdosing, starting with psilocybin. The public health potential of microdosing is undeniable, but your support is needed. Support research and advocacy efforts with a donation to the Microdosing Collective today. 

Join the Movement to Support Safe, Equitable Access to Psychedelic Medicines in Colorado

Healing Advocacy Fund Colorado (HAF) exists to support safe, equitable and effective implementation of the Natural Medicine Health Act, with the hope that Colorado can serve as a model for thoughtful and ethical reform. Grounded in values of safety, inclusivity, equity and responsibility, the organization intends to foster opportunities for community participation as this implementation journey unfolds.

  • Sign up for HAF’s newsletter for news, updates, events and research around the implementation of the NMHA
  • Donate to HAF. Your charitable donation supports safe, equitable access to psilocybin therapy for those who need it

Complete this Participant Survey!

If you are interested in opening up a business under the NMHA, please complete this survey from the Department of Revenue.

Your input at this time is critical. 


SXSW 2024 + ATX Psychedelics and Cannabis Opening Night Party

Did you miss Vicente LLP at SXSW this year? Not only did partners Joshua Kappel and Shawn Hauser provide amazing insights on their Psychedelics Track panels, but the ATX Psychedelics and Cannabis Opening Night Party to raise funds for the non-profit Field to Healed, co-hosted by Grasslands: Journalism-Minded Agency™, was a success! Thank you to our amazing sponsors, Cantrip and Rare Earth Genomics, for helping to make it all possible.

April 18 | Bridging the Worlds: The Confluence of Indigenous Wisdom and Psychedelic Science

Vicente psychedelics attorneys Joshua Kappel and Barine Majewska will attend Bridging the Worlds: The Confluence of Indigenous Wisdom and Psychedelic Science Conference at the University of Colorado Anschutz Medical Campus in Aurora, CO.

Register here to attend various panels centered around the connection between psychedelics/plant medicines and their cultural and historical sacred traditions within communities. 

April 27-28 | Psychedelic Culture 2024

We're proud to sponsor Chacruna Institute's Psychedelic Culture 2024 in San Francisco! Look out for our attorneys Joshua Kappel and Barine Majewska, who will be in attendance. Contact us if you'd like to meet up! 

May 31 - June 2 | Aspen Public Radio Psychedelics Symposium

This June, Vicente LLP is headed to the Aspen Public Radio Psychedelics Symposium, co-hosted by the Healing Advocacy Fund! Vicente founding partner Joshua Kappel is slated to speak on a panel surrounding Colorado’s Natural Medicine. Click here to learn more and contact us to set up a meeting while we're there!

To access Psychedelics & Emerging Therapies-related legislative summaries, regulatory updates, licensing information, informational webinars and events from Vicente LLP, simply bookmark this webpage.

The content and links provided on this page are for informational purposes only and not for the purpose of providing legal or tax advice. Viewing this page does not establish an attorney-client relationship. You should consult with a qualified legal professional for advice regarding any particular issue or problem. The contents of this page may be considered attorney advertising under certain rules of professional conduct.